Abstract
Endocrine disorders (except diabetes mellitus) represent an infrequent cause of erectile dysfunction. However, identification of an endocrine disorder in these patients is essential for three major reasons. First, it provides an opportunity for etiologic management of erectile dysfunction instead of symptomatic. Second, endocrine disorders associated with erectile dysfunction might also have important adverse sequelae on the general health and should therefore be timely identified and managed. Third, a limited panel of hormonal tests (i.e., serum total testosterone, thyrotropin, and prolactin levels) is frequently sufficient for reaching a diagnosis of these endocrine disorders. In the present chapter, the endocrine disorders most frequently associated with erectile dysfunction are discussed, with emphasis on their prevalence in patients with erectile dysfunction, the diagnostic work-up, and the effects of their management on erectile function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Araujo AB, Esche GR, Kupelian V, O’Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92:4241–4247
Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724–731
Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87:589–598
Korenman SG, Morley JE, Mooradian AD, Davis SS, Kaiser FE, Silver AJ, Viosca SP, Garza D (1990) Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab 71:963–969
Rhoden EL, Telöken C, Sogari PR, Souto CA (2002) The relationship of serum testosterone to erectile function in normal aging men. J Urol 167:1745–1748
Shamloul R, Ghanem H (2013) Erectile dysfunction. Lancet 381:153–165
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM, Task Force, Endocrine Society (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95:2536–2559
Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A, Zitzmann M (2010) Endocrine aspects of male sexual dysfunctions. J Sex Med 7:1627–1656
Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E, European Association of Urology (2010) Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 57:804–814
Buvat J, Lemaire A (1997) Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol 158:1764–1767
McVary KT (2007) Clinical practice. Erectile dysfunction. N Engl J Med 357:2472–2481
Brambilla DJ, O’Donnell AB, Matsumoto AM, McKinlay JB (2007) Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin Endocrinol Oxf 67:853–862
Citron JT, Ettinger B, Rubinoff H, Ettinger VM, Minkoff J, Hom F, Kan P, Alloo R (1996) Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism. J Urol 155:529–533
Boloña ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC, Caples SM, Erwin PJ, Montori VM (2007) Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 82:20–28
Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H (2004) Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172:658–663
Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S (2005) Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 60:1451–1457
Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A, Choong K, Lakshman KM, Mazer NA, Miciek R, Krasnoff J, Elmi A, Knapp PE, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore LD, Bhasin S (2010) Adverse events associated with testosterone administration. N Engl J Med 363:109–122
Vigen R, O’Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM (2013) Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310:1829–1836
Bhasin S, Enzlin P, Coviello A, Basson R (2007) Sexual dysfunction in men and women with endocrine disorders. Lancet 369:597–611
De Rosa M, Zarrilli S, Vitale G, Di Somma C, Orio F, Tauchmanova’ L, Lombardi G, Colao A (2004) Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence. J Clin Endocrinol Metab 89:621–625
Delavierre D, Girard P, Peneau M, Ibrahim H (1999) Should plasma prolactin assay be routinely performed in the assessment of erectile dysfunction? Report of a series of 445 patients. Review of the literature. Prog Urol 9:1097–1101
Slag MF, Morley JE, Elson MK, Trence DL, Nelson CJ, Nelson AE, Kinlaw WB, Beyer HS, Nuttall FQ, Shafer RB (1983) Impotence in medical clinic outpatients. JAMA 249:1736–1740
Krassas GE, Tziomalos K, Papadopoulou F, Pontikides N, Perros P (2008) Erectile dysfunction in patients with hyper- and hypothyroidism: how common and should we treat? J Clin Endocrinol Metab 93:1815–1819
Krassas GE, Poppe K, Glinoer D (2010) Thyroid function and human reproductive health. Endocr Rev 31:702–755
Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA (2005) Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 90:6472–6479
Soran H, Wu FC (2005) Endocrine causes of erectile dysfunction. Int J Androl 28(Suppl 2):28–34
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tziomalos, K., Athyros, V.G. (2015). Endocrine Disorders and Erectile Dysfunction. In: Viigimaa, M., Vlachopoulos, C., Doumas, M. (eds) Erectile Dysfunction in Hypertension and Cardiovascular Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-08272-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-08272-1_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-08271-4
Online ISBN: 978-3-319-08272-1
eBook Packages: MedicineMedicine (R0)